APO RESEARCH · REPORT
Hemostatic Forceps
Hemostatic Forceps (also called a Hemostat) is a surgical tool used in many surgical procedures to control bleeding or the flow of liquids in tubing. They have ring handles just like scissors. The ratcheted handles can be locked in multiple positions in order to maintain variable levels of constant pressure.
Product & engineering
Understand the product.
Hemostatic Forceps (also called a Hemostat) is a surgical tool used in many surgical procedures to control bleeding or the flow of liquids in tubing. They have ring handles just like scissors. The ratcheted handles can be locked in multiple positions in order to maintain variable levels of constant pressure.
For different application, there are generally three types of hemostatic forceps, which include Halstead mosquito hemostatic forceps, Kelly and Crile hemostatic forceps and Rochester-Carmalt hemostatic forceps.
Selected research
Industry Growth & Trends
Global Hemostatic Forceps Industry Growth and Trends Forecast to 2032
Market perspective
Hemostatic Forceps (also called a Hemostat) is a surgical tool used in many surgical procedures to control bleeding or the flow of liquids in tubing. They have ring handles just like scissors. The ratcheted handles can be locked in multiple positions in order to maintain variable levels of constant pressure.
For different application, there are generally three types of hemostatic forceps, which include Halstead mosquito hemostatic forceps, Kelly and Crile hemostatic forceps and Rochester-Carmalt hemostatic forceps.
Global Hemostatic Forceps key players include Medline, B. Braun, CareFusion, Sklar, Scanlan International, etc. Global top five manufacturers hold a share over 45%.
Read the full market overview
North America is the largest market, with a share over 30%, followed by Europe and China, both have a share about 45%.
In terms of product, Halstead Mosquito Hemostatic Forceps is the largest segment, with a share over 55%.
Report Scope
This report provides a structured, data-driven view of the global Hemostatic Forceps market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Hemostatic Forceps market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Hemostatic Forceps market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Hemostatic Forceps.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Hemostatic Forceps market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Hemostatic Forceps Market by Company
Medline
B. Braun
CareFusion
Asa Dental
Sklar
Scanlan International
Shanghai Medical Instruments
Lawton
Hu-Friedy
Xinhua Surgical
Towne Brothers
Teleflex Medical
Delacroix Chevalier
YDM
M A Corporation
MedGyn Products
Inami
Ted Pella
Medicon eG
J & J Instruments
American Diagnostic
Hemostatic Forceps Segment by Type
Halstead Mosquito Hemostatic Forceps
Kelly and Crile Hemostatic Forceps
Rochester-Carmalt Hemostatic Forceps
Hemostatic Forceps Segment by Application
Surgical
Dissection
Dental
Laparoscopic
Others
Hemostatic Forceps Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hemostatic Forceps market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hemostatic Forceps and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hemostatic Forceps.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hemostatic Forceps manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Hemostatic Forceps in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Halstead Mosquito Hemostatic Forceps
- Kelly and Crile Hemostatic Forceps
- Rochester-Carmalt Hemostatic Forceps
Applications
- Surgical
- Dissection
- Dental
- Laparoscopic
- Others
Companies covered
- Medline
- B. Braun
- CareFusion
- Asa Dental
- Sklar
- Scanlan International
- Shanghai Medical Instruments
- Lawton
- Hu-Friedy
- Xinhua Surgical
- Towne Brothers
- Teleflex Medical
- Delacroix Chevalier
- YDM
- M A Corporation
- MedGyn Products
- Inami
- Ted Pella
- Medicon eG
- J & J Instruments
- American Diagnostic
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Hemostatic Forceps Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Hemostatic Forceps Sales Estimates and Forecasts (2021-2032)
- 1.3 Hemostatic Forceps Market by Type
- 1.3.1 Halstead Mosquito Hemostatic Forceps
- 1.3.2 Kelly and Crile Hemostatic Forceps
- 1.3.3 Rochester-Carmalt Hemostatic Forceps
- 1.4 Global Hemostatic Forceps Market Size by Type
- 1.4.1 Global Hemostatic Forceps Market Size Overview by Type (2021-2032)
- 1.4.2 Global Hemostatic Forceps Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Hemostatic Forceps Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Hemostatic Forceps Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Hemostatic Forceps Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Hemostatic Forceps Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Hemostatic Forceps Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Hemostatic Forceps Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Hemostatic Forceps Industry Trends
- 2.2 Hemostatic Forceps Industry Drivers
- 2.3 Hemostatic Forceps Industry Opportunities and Challenges
- 2.4 Hemostatic Forceps Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Hemostatic Forceps Revenue (2021-2026)
- 3.2 Global Top Players by Hemostatic Forceps Sales (2021-2026)
- 3.3 Global Top Players by Hemostatic Forceps Price (2021-2026)
- 3.4 Global Hemostatic Forceps Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Hemostatic Forceps Major Company Production Sites & Headquarters
- 3.6 Global Hemostatic Forceps Company, Product Type & Application
- 3.7 Global Hemostatic Forceps Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Hemostatic Forceps Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Hemostatic Forceps Players Market Share by Revenue in 2025
- 3.8.3 2025 Hemostatic Forceps Tier 1, Tier 2, and Tier 3
4 Hemostatic Forceps Regional Status and Outlook
- 4.1 Global Hemostatic Forceps Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Hemostatic Forceps Historic Market Size by Region
- 4.2.1 Global Hemostatic Forceps Sales in Volume by Region (2021-2026)
- 4.2.2 Global Hemostatic Forceps Sales in Value by Region (2021-2026)
- 4.2.3 Global Hemostatic Forceps Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Hemostatic Forceps Forecasted Market Size by Region
- 4.3.1 Global Hemostatic Forceps Sales in Volume by Region (2027-2032)
- 4.3.2 Global Hemostatic Forceps Sales in Value by Region (2027-2032)
- 4.3.3 Global Hemostatic Forceps Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Hemostatic Forceps by Application
- 5.1 Hemostatic Forceps Market by Application
- 5.1.1 Surgical
- 5.1.2 Dissection
- 5.1.3 Dental
- 5.1.4 Laparoscopic
- 5.1.5 Others
- 5.2 Global Hemostatic Forceps Market Size by Application
- 5.2.1 Global Hemostatic Forceps Market Size Overview by Application (2021-2032)
- 5.2.2 Global Hemostatic Forceps Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Hemostatic Forceps Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Hemostatic Forceps Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Hemostatic Forceps Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Hemostatic Forceps Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Hemostatic Forceps Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Hemostatic Forceps Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Medline
- 6.1.1 Medline Company Information
- 6.1.2 Medline Business Overview
- 6.1.3 Medline Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Medline Hemostatic Forceps Product Portfolio
- 6.1.5 Medline Recent Developments
- 6.2 B. Braun
- 6.2.1 B. Braun Company Information
- 6.2.2 B. Braun Business Overview
- 6.2.3 B. Braun Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 B. Braun Hemostatic Forceps Product Portfolio
- 6.2.5 B. Braun Recent Developments
- 6.3 CareFusion
- 6.3.1 CareFusion Company Information
- 6.3.2 CareFusion Business Overview
- 6.3.3 CareFusion Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 CareFusion Hemostatic Forceps Product Portfolio
- 6.3.5 CareFusion Recent Developments
- 6.4 Asa Dental
- 6.4.1 Asa Dental Company Information
- 6.4.2 Asa Dental Business Overview
- 6.4.3 Asa Dental Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Asa Dental Hemostatic Forceps Product Portfolio
- 6.4.5 Asa Dental Recent Developments
- 6.5 Sklar
- 6.5.1 Sklar Company Information
- 6.5.2 Sklar Business Overview
- 6.5.3 Sklar Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Sklar Hemostatic Forceps Product Portfolio
- 6.5.5 Sklar Recent Developments
- 6.6 Scanlan International
- 6.6.1 Scanlan International Company Information
- 6.6.2 Scanlan International Business Overview
- 6.6.3 Scanlan International Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Scanlan International Hemostatic Forceps Product Portfolio
- 6.6.5 Scanlan International Recent Developments
- 6.7 Shanghai Medical Instruments
- 6.7.1 Shanghai Medical Instruments Company Information
- 6.7.2 Shanghai Medical Instruments Business Overview
- 6.7.3 Shanghai Medical Instruments Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Shanghai Medical Instruments Hemostatic Forceps Product Portfolio
- 6.7.5 Shanghai Medical Instruments Recent Developments
- 6.8 Lawton
- 6.8.1 Lawton Company Information
- 6.8.2 Lawton Business Overview
- 6.8.3 Lawton Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Lawton Hemostatic Forceps Product Portfolio
- 6.8.5 Lawton Recent Developments
- 6.9 Hu-Friedy
- 6.9.1 Hu-Friedy Company Information
- 6.9.2 Hu-Friedy Business Overview
- 6.9.3 Hu-Friedy Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Hu-Friedy Hemostatic Forceps Product Portfolio
- 6.9.5 Hu-Friedy Recent Developments
- 6.10 Xinhua Surgical
- 6.10.1 Xinhua Surgical Company Information
- 6.10.2 Xinhua Surgical Business Overview
- 6.10.3 Xinhua Surgical Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Xinhua Surgical Hemostatic Forceps Product Portfolio
- 6.10.5 Xinhua Surgical Recent Developments
- 6.11 Towne Brothers
- 6.11.1 Towne Brothers Company Information
- 6.11.2 Towne Brothers Business Overview
- 6.11.3 Towne Brothers Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Towne Brothers Hemostatic Forceps Product Portfolio
- 6.11.5 Towne Brothers Recent Developments
- 6.12 Teleflex Medical
- 6.12.1 Teleflex Medical Company Information
- 6.12.2 Teleflex Medical Business Overview
- 6.12.3 Teleflex Medical Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Teleflex Medical Hemostatic Forceps Product Portfolio
- 6.12.5 Teleflex Medical Recent Developments
- 6.13 Delacroix Chevalier
- 6.13.1 Delacroix Chevalier Company Information
- 6.13.2 Delacroix Chevalier Business Overview
- 6.13.3 Delacroix Chevalier Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Delacroix Chevalier Hemostatic Forceps Product Portfolio
- 6.13.5 Delacroix Chevalier Recent Developments
- 6.14 YDM
- 6.14.1 YDM Company Information
- 6.14.2 YDM Business Overview
- 6.14.3 YDM Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 YDM Hemostatic Forceps Product Portfolio
- 6.14.5 YDM Recent Developments
- 6.15 M A Corporation
- 6.15.1 M A Corporation Company Information
- 6.15.2 M A Corporation Business Overview
- 6.15.3 M A Corporation Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 M A Corporation Hemostatic Forceps Product Portfolio
- 6.15.5 M A Corporation Recent Developments
- 6.16 MedGyn Products
- 6.16.1 MedGyn Products Company Information
- 6.16.2 MedGyn Products Business Overview
- 6.16.3 MedGyn Products Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
- 6.16.4 MedGyn Products Hemostatic Forceps Product Portfolio
- 6.16.5 MedGyn Products Recent Developments
- 6.17 Inami
- 6.17.1 Inami Company Information
- 6.17.2 Inami Business Overview
- 6.17.3 Inami Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
- 6.17.4 Inami Hemostatic Forceps Product Portfolio
- 6.17.5 Inami Recent Developments
- 6.18 Ted Pella
- 6.18.1 Ted Pella Company Information
- 6.18.2 Ted Pella Business Overview
- 6.18.3 Ted Pella Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
- 6.18.4 Ted Pella Hemostatic Forceps Product Portfolio
- 6.18.5 Ted Pella Recent Developments
- 6.19 Medicon eG
- 6.19.1 Medicon eG Company Information
- 6.19.2 Medicon eG Business Overview
- 6.19.3 Medicon eG Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
- 6.19.4 Medicon eG Hemostatic Forceps Product Portfolio
- 6.19.5 Medicon eG Recent Developments
- 6.20 J & J Instruments
- 6.20.1 J & J Instruments Company Information
- 6.20.2 J & J Instruments Business Overview
- 6.20.3 J & J Instruments Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
- 6.20.4 J & J Instruments Hemostatic Forceps Product Portfolio
- 6.20.5 J & J Instruments Recent Developments
- 6.21 American Diagnostic
- 6.21.1 American Diagnostic Company Information
- 6.21.2 American Diagnostic Business Overview
- 6.21.3 American Diagnostic Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
- 6.21.4 American Diagnostic Hemostatic Forceps Product Portfolio
- 6.21.5 American Diagnostic Recent Developments
7 North America by Country
- 7.1 North America Hemostatic Forceps Sales by Country
- 7.1.1 North America Hemostatic Forceps Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Hemostatic Forceps Sales by Country (2021-2026)
- 7.1.3 North America Hemostatic Forceps Sales Forecast by Country (2027-2032)
- 7.2 North America Hemostatic Forceps Market Size by Country
- 7.2.1 North America Hemostatic Forceps Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Hemostatic Forceps Market Size by Country (2021-2026)
- 7.2.3 North America Hemostatic Forceps Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Hemostatic Forceps Sales by Country
- 8.1.1 Europe Hemostatic Forceps Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Hemostatic Forceps Sales by Country (2021-2026)
- 8.1.3 Europe Hemostatic Forceps Sales Forecast by Country (2027-2032)
- 8.2 Europe Hemostatic Forceps Market Size by Country
- 8.2.1 Europe Hemostatic Forceps Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Hemostatic Forceps Market Size by Country (2021-2026)
- 8.2.3 Europe Hemostatic Forceps Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Hemostatic Forceps Sales by Country
- 9.1.1 Asia-Pacific Hemostatic Forceps Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Hemostatic Forceps Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Hemostatic Forceps Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Hemostatic Forceps Market Size by Country
- 9.2.1 Asia-Pacific Hemostatic Forceps Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Hemostatic Forceps Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Hemostatic Forceps Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Hemostatic Forceps Sales by Country
- 10.1.1 South America Hemostatic Forceps Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Hemostatic Forceps Sales by Country (2021-2026)
- 10.1.3 South America Hemostatic Forceps Sales Forecast by Country (2027-2032)
- 10.2 South America Hemostatic Forceps Market Size by Country
- 10.2.1 South America Hemostatic Forceps Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Hemostatic Forceps Market Size by Country (2021-2026)
- 10.2.3 South America Hemostatic Forceps Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Hemostatic Forceps Sales by Country
- 11.1.1 Middle East and Africa Hemostatic Forceps Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Hemostatic Forceps Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Hemostatic Forceps Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Hemostatic Forceps Market Size by Country
- 11.2.1 Middle East and Africa Hemostatic Forceps Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Hemostatic Forceps Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Hemostatic Forceps Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Hemostatic Forceps Value Chain Analysis
- 12.1.1 Hemostatic Forceps Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Hemostatic Forceps Production Mode & Process
- 12.2 Hemostatic Forceps Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Hemostatic Forceps Distributors
- 12.2.3 Hemostatic Forceps Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst